Question 1

Does Two Sigma Advisers own NTLA stock?

Accepted Answer

Yes. As of its Q4 2025 13F, Two Sigma Advisers holds 2,346,317 shares of NTLA (Intellia Therapeutics), worth $21.1M.

Question 2

How many shares of NTLA does Two Sigma Advisers own?

Accepted Answer

As of its Q4 2025 13F, Two Sigma Advisers holds 2,346,317 shares of NTLA (Intellia Therapeutics).

Question 3

What is Two Sigma Advisers' NTLA position worth?

Accepted Answer

As of its Q4 2025 13F, Two Sigma Advisers' NTLA position is worth $21.1M.

Question 4

Is Two Sigma Advisers buying or selling NTLA?

Accepted Answer

In Q4 2025, Two Sigma Advisers increased its NTLA position by 182,900 shares (+8.5%).

Question 5

When did Two Sigma Advisers first buy NTLA?

Accepted Answer

Two Sigma Advisers already held NTLA in its Q4 2018 13F, the earliest on record, and has listed it in 29 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Increased	2.3M	+8.4%	$21.1M	0.0%	$8.99	31
2025-Q3	Increased	2.2M	+3.4%	$37.4M	0.1%	$17.27	30
2025-Q2	Increased	2.1M	+5.6%	$19.6M	0.0%	$9.38	30
2025-Q1	Decreased	2M	-0.8%	$14.1M	0.0%	$7.11	0
2024-Q4	Increased	2M	+94.5%	$23.3M	0.1%	$11.66	45
2024-Q3	Increased	1M	+33.5%	$21.1M	0.0%	$20.55	37